Biobanking Market size was valued at USD 72 billion in 2023 to USD 95.5 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031). The driving forces include large expenditures on the R&D of cutting-edge therapeutics, such as cancer genomic studies, personalised medicine, and regenerative medicine. Additionally, since COVID-19 first appeared, biobanks have been at the forefront of pandemic containment efforts, which has led to the market’s organic revenue growth. The COVID-19 pandemic had a major influence on the biobanking market. Biobanking has a crucial role to play in the diagnosis and drug development of various diseases. Thus, there is an international demand for rapid responses towards the development of vaccines and other antiviral agents.
Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/biobanking-market
Exploring the Leaders in Genetic Data, Precision Medicine, and Cryogenic Storage Solutions
The global biobanking market exhibits a highly competitive environment with leading companies actively engaged in various business lines such as sample repository solutions, management of genetic information, and tailored healthcare. AMS Biotechnology (Europe) Ltd., ASKION GmbH, Avantor, Inc. and Azenta, Inc. outstrip other competitors in sample processing and storage equipment, while CTI Biotech, Firalis SA and BioIVT focus on research and diagnostics enabled through biobanks. Cryopreservation, mechanization, and collaborations geared towards the progression of precision and genomic medicine studies are some of the factors fuelling the growth of the market.
International Power Players Pushing the Boundaries of Genetic Innovation
The global biobanking market is cut-throat mainly due to the presence of key global players who are focused on innovation in the areas of sample storage, genetic data management and personalized medicine among others. For instance, AMS Biotechnology (Europe) Ltd. and ASKION GmbH are very strong in the areas of cryopreservation and automation while the likes of Avantor, Inc. and Azenta, Inc. are well known for their sample handling systems.
Research-focused firms like CTI Biotech and BioIVT fuel innovation in diagnostics and genomic studies. Global collaborations and technological breakthroughs continue to propel growth, shaping the future of precision medicine and genetic research worldwide.
For a tailored report, contact us to request a free customization: https://www.skyquestt.com/sample-request/biobanking-market
Strategies and Innovations Driving the Competitive Edge of Biobanking
Oligopoly of the global biobanking market can be illustrated by examples such as Avantor, Inc., which has bought Masterflex in order to reinforce its sample handling technologies, thus elevating its competitive advantage in biobanking. Azenta, Inc. has invested into better mechanization systems in order to decrease the operational cost of cryopreservation which is growing in demand with the precision medicine sector. Similarly, CTI Biotech works hand in hand with pharmaceutical companies to further the principles of personalized medicine. On the other hand, ASKION GmbH has provided the market with automated solutions for the implementation of cryogenic storage systems while BioIVT aims to grow its biobanks that deals with tissues as well as blood all over the world for the purposes of supporting genetics and diagnosis evolution.
This report covers the following segments:
A. Type
Population-based Biobanks
Disease-based Biobanks
Academic Biobanks
Hospital-based Biobanks
B. Sample
Blood Products
Cell Lines
Nucleic Acids
Human Tissues
C. Application
Drug Discovery
Genomic Research
Personalized Medicine
Regenerative Medicine
The report covers the following players:
AMS Biotechnology (Europe) Ltd.
ASKION GmbH
Avantor, Inc.
Azenta, Inc. (Azenta)
Bay Biosciences LLC
BioIVT & Elevating Science
Boca Biolistics
CTI Biotech
Cureline Inc.
Firalis SA
Geneticist Inc.
Hamilton Bonaduz AG
Isenet Biobanking
Merck & Co., Inc.
ProteoGenex Inc.
Qiagen NV
Stemcell Holdings, Inc.
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.
US Biolab Corp. Inc.
Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/biobanking-market
Biobanking Titans Are Pioneering Precision Medicine and Revolutionizing Therapeutics
The global biobanking market is growing at a rapid pace due to the developments in genomic research, personalized medicine and precision treatments. In this regard, the competitive advantage in automation and storage of samples is provided by major corporations such as Avantor, Inc. and Azenta, Inc. On the other hand, players such as CTI Biotech and BioIVT encourage focused research partnerships. The expansion of this segment is also owing to the contribution of biobanks in the battle against COVID-19 further emphasizing their significance in disease diagnostics and therapies development. The progress that is always evident is bound to continue revolutionizing healthcare and bio medicine across the world.
To read the full report, please visit: https://www.skyquestt.com/report/biobanking-market
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/biobanking-market